Zura Bio Limited Net Income
| ZURA Stock | 6.21 0.05 0.80% |
As of the 13th of February 2026, Zura Bio maintains the Downside Deviation of 5.22, mean deviation of 3.98, and Market Risk Adjusted Performance of 0.5614. Relative to fundamental indicators, the technical analysis model lets you check existing technical drivers of Zura Bio Limited, as well as the relationship between them.
Zura Bio's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Zura Bio's valuation are provided below:We have found ninety-five available fundamental gauges for Zura Bio Limited, which can be analyzed and compared to other ratios and to its peers. All investors should make sure to confirm all of Zura Bio Limited prevalent market performance against the performance between 2010 and 2026 to make sure the company can sustain itself down the road. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. | Last Reported | Projected for Next Year | ||
| Net Loss | -40.6 M | -42.7 M | |
| Net Loss | -47.2 M | -49.5 M | |
| Net Loss | -47.2 M | -49.5 M | |
| Net Loss | (0.80) | (0.84) | |
| Net Income Per E B T | 0.90 | 0.78 |
Zura | Net Income | Build AI portfolio with Zura Stock |
Analyzing Zura Bio's Net Income over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income has evolved provides context for assessing Zura Bio's current valuation and future prospects.
Latest Zura Bio's Net Income Growth Pattern
Below is the plot of the Net Income of Zura Bio Limited over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Zura Bio Limited financial statement analysis. It represents the amount of money remaining after all of Zura Bio Limited operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Zura Bio's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Zura Bio's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (52.4 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Zura Net Income Regression Statistics
| Arithmetic Mean | (7,893,177) | |
| Coefficient Of Variation | (339.94) | |
| Mean Deviation | 23,025,723 | |
| Median | 8,416,710 | |
| Standard Deviation | 26,832,159 | |
| Sample Variance | 720T | |
| Range | 68.8M | |
| R-Value | (0.78) | |
| Mean Square Error | 296.9T | |
| R-Squared | 0.61 | |
| Significance | 0.0002 | |
| Slope | (4,161,708) | |
| Total Sum of Squares | 11519.4T |
Zura Net Income History
Other Fundumenentals of Zura Bio Limited
| Net Income Applicable To Common Shares | ||
| Net Income From Continuing Ops | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Zura Bio Net Income component correlations
Zura Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Zura Bio is extremely important. It helps to project a fair market value of Zura Stock properly, considering its historical fundamentals such as Net Income. Since Zura Bio's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Zura Bio's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Zura Bio's interrelated accounts and indicators.
Click cells to compare fundamentals
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zura Bio. Anticipated expansion of Zura directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Zura Bio assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Understanding Zura Bio Limited requires distinguishing between market price and book value, where the latter reflects Zura's accounting equity. The concept of intrinsic value - what Zura Bio's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Zura Bio's price substantially above or below its fundamental value.
Please note, there is a significant difference between Zura Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zura Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Zura Bio's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Zura Bio 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Zura Bio's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Zura Bio.
| 11/15/2025 |
| 02/13/2026 |
If you would invest 0.00 in Zura Bio on November 15, 2025 and sell it all today you would earn a total of 0.00 from holding Zura Bio Limited or generate 0.0% return on investment in Zura Bio over 90 days. Zura Bio is related to or competes with Assembly Biosciences, Foghorn Therapeutics, Immuneering Corp, Sagimet Biosciences, Nautilus Biotechnology, Aardvark Therapeutics, and Arcturus Therapeutics. Zura Bio is entity of United States. It is traded as Stock on NASDAQ exchange. More
Zura Bio Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Zura Bio's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Zura Bio Limited upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.22 | |||
| Information Ratio | 0.1488 | |||
| Maximum Drawdown | 33.15 | |||
| Value At Risk | (7.00) | |||
| Potential Upside | 9.53 |
Zura Bio Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Zura Bio's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Zura Bio's standard deviation. In reality, there are many statistical measures that can use Zura Bio historical prices to predict the future Zura Bio's volatility.| Risk Adjusted Performance | 0.1405 | |||
| Jensen Alpha | 0.8357 | |||
| Total Risk Alpha | 0.4389 | |||
| Sortino Ratio | 0.1699 | |||
| Treynor Ratio | 0.5514 |
Zura Bio February 13, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1405 | |||
| Market Risk Adjusted Performance | 0.5614 | |||
| Mean Deviation | 3.98 | |||
| Semi Deviation | 4.34 | |||
| Downside Deviation | 5.22 | |||
| Coefficient Of Variation | 615.96 | |||
| Standard Deviation | 5.97 | |||
| Variance | 35.6 | |||
| Information Ratio | 0.1488 | |||
| Jensen Alpha | 0.8357 | |||
| Total Risk Alpha | 0.4389 | |||
| Sortino Ratio | 0.1699 | |||
| Treynor Ratio | 0.5514 | |||
| Maximum Drawdown | 33.15 | |||
| Value At Risk | (7.00) | |||
| Potential Upside | 9.53 | |||
| Downside Variance | 27.3 | |||
| Semi Variance | 18.81 | |||
| Expected Short fall | (4.55) | |||
| Skewness | 1.03 | |||
| Kurtosis | 4.66 |
Zura Bio Limited Backtested Returns
Zura Bio appears to be moderately volatile, given 3 months investment horizon. Zura Bio Limited shows Sharpe Ratio of 0.15, which attests that the company had a 0.15 % return per unit of risk over the last 3 months. By examining Zura Bio's technical indicators, you can evaluate if the expected return of 0.9% is justified by implied risk. Please utilize Zura Bio's Mean Deviation of 3.98, downside deviation of 5.22, and Market Risk Adjusted Performance of 0.5614 to validate if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Zura Bio holds a performance score of 12. The firm maintains a market beta of 1.74, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Zura Bio will likely underperform. Please check Zura Bio's skewness, and the relationship between the potential upside and rate of daily change , to make a quick decision on whether Zura Bio's historical returns will revert.
Auto-correlation | 0.56 |
Modest predictability
Zura Bio Limited has modest predictability. Overlapping area represents the amount of predictability between Zura Bio time series from 15th of November 2025 to 30th of December 2025 and 30th of December 2025 to 13th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Zura Bio Limited price movement. The serial correlation of 0.56 indicates that roughly 56.0% of current Zura Bio price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.56 | |
| Spearman Rank Test | 0.49 | |
| Residual Average | 0.0 | |
| Price Variance | 0.33 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Zura Bio Limited reported net income of (52.4 Million). This is 115.35% lower than that of the Biotechnology sector and 174.81% lower than that of the Health Care industry. The net income for all United States stocks is 109.18% higher than that of the company.
Zura Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Zura Bio's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Zura Bio could also be used in its relative valuation, which is a method of valuing Zura Bio by comparing valuation metrics of similar companies.Zura Bio is currently under evaluation in net income category among its peers.
Zura Bio ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Zura Bio's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Zura Bio's managers, analysts, and investors.Environmental | Governance | Social |
Zura Fundamentals
| Return On Equity | -0.45 | ||||
| Return On Asset | -0.27 | ||||
| Current Valuation | 268.03 M | ||||
| Shares Outstanding | 65.02 M | ||||
| Shares Owned By Insiders | 24.49 % | ||||
| Shares Owned By Institutions | 68.28 % | ||||
| Number Of Shares Shorted | 3.85 M | ||||
| Price To Book | 3.86 X | ||||
| EBITDA | (55.18 M) | ||||
| Net Income | (52.4 M) | ||||
| Total Debt | 19.51 M | ||||
| Book Value Per Share | 1.67 X | ||||
| Cash Flow From Operations | (28.08 M) | ||||
| Short Ratio | 4.22 X | ||||
| Earnings Per Share | (0.65) X | ||||
| Target Price | 15.5 | ||||
| Number Of Employees | 30 | ||||
| Beta | 0.21 | ||||
| Market Capitalization | 407.05 M | ||||
| Total Asset | 179.53 M | ||||
| Retained Earnings | (155.9 M) | ||||
| Working Capital | 159.23 M | ||||
| Net Asset | 179.53 M |
About Zura Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Zura Bio Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Zura Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Zura Bio Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Zura Bio Limited offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Zura Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zura Bio Limited Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zura Bio Limited Stock:Check out You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zura Bio. Anticipated expansion of Zura directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Zura Bio assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Understanding Zura Bio Limited requires distinguishing between market price and book value, where the latter reflects Zura's accounting equity. The concept of intrinsic value - what Zura Bio's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Zura Bio's price substantially above or below its fundamental value.
Please note, there is a significant difference between Zura Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zura Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Zura Bio's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.